Danone Acquires The Akkermansia Company
Danone invests further in gut health and next-generation biotic science
IMAGE COURTESY OF: Danone
The Akkermansia Company (TAC) announced that it has been acquired by Danone, a leading global food and beverage company.
TAC’s founding scientists first discovered the biotic strain Akkermansia muciniphila MucT in 2004 and have since developed it using state-of-the-art technology. They clinically demonstrated its power to reinforce the gut barrier, reduce inflammation, and counteract metabolic disorders such as obesity, diabetes and cardiovascular disease.
The company has broad patents protecting the use of the Akkermansia species, including the use of the pasteurized version of the strain, MucT, which is its most bio-efficacious form.
TAC is successfully expanding business into key markets in Europe, North America and Asia.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!
